Eliot A. Brinton

Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

Deepak L. Bhatt, Philippe Gabríel Steg, Michael Miller et al. · New England Journal of Medicine · 2018 · 3.2K citations

Medicine, Cardiology, Pharmacology +14

American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for Management of Dyslipidemia and Prevention of Cardiovascular Disease

Paul S. Jellinger, Yehuda Handelsman, Paul D. Rosenblit et al. · Endocrine Practice · 2017 · 1.1K citations

Medicine, Endocrinology, Internal Medicine +16

Weight and Metabolic Outcomes 12 Years after Gastric Bypass

Ted D. Adams, Lance E. Davidson, Sheldon E. Litwin et al. · New England Journal of Medicine · 2017 · 933 citations · Full text

Medicine, Endocrinology, Surgery +14

Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease

Christopher P. Cannon, Sukrut Shah, Hayes M. Dansky et al. · New England Journal of Medicine · 2010 · 754 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk

Aruna D. Pradhan, Robert J. Glynn, Jean‐Charles Fruchart et al. · New England Journal of Medicine · 2022 · 711 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16